1. Home
  2. SKLZ vs LPCN Comparison

SKLZ vs LPCN Comparison

Compare SKLZ & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skillz Inc.

SKLZ

Skillz Inc.

HOLD

Current Price

$2.87

Market Cap

57.3M

Sector

Technology

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$6.92

Market Cap

61.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKLZ
LPCN
Founded
2012
1997
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.3M
61.8M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
SKLZ
LPCN
Price
$2.87
$6.92
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$14.00
$15.00
AVG Volume (30 Days)
34.6K
123.9K
Earning Date
05-07-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
45.98
46.18
EPS
N/A
N/A
Revenue
$92,865,000.00
$1,976,677.00
Revenue This Year
$13.33
N/A
Revenue Next Year
$12.68
$74.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.10
$2.52
52 Week High
$9.11
$12.37

Technical Indicators

Market Signals
Indicator
SKLZ
LPCN
Relative Strength Index (RSI) 36.99 36.50
Support Level N/A $2.87
Resistance Level $3.68 $10.68
Average True Range (ATR) 0.18 0.67
MACD -0.01 -0.17
Stochastic Oscillator 0.00 2.11

Price Performance

Historical Comparison
SKLZ
LPCN

About SKLZ Skillz Inc.

Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. The company's reportable business segments are: the Skillz segment and the Aarki segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is an artificial intelligence company that delivers advertising solutions. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The majority of its revenue is generated from the Skillz segment. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: